DOCSLIB.ORG

(12) Patent Application Publication (10) Pub. No.: US 2007/0128662 A1 Isacoff Et Al

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
(12) Patent Application Publication (10) Pub. No.: US 2007/0128662 A1 Isacoff Et Al US 2007.0128662A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2007/0128662 A1 Isacoff et al. (43) Pub. Date: Jun. 7, 2007 (54) PHOTOREACTIVE REGULATOR OF Publication Classification PROTEIN FUNCTION AND METHODS OF USE THEREOF (51) Int. Cl. GOIN 33/53 (2006.01) (76) Inventors: Ehud Y. Isacoff, Berkeley, CA (US); C07K I4/95 (2006.01) Richard H. Kramer, Oakland, CA C7H 2L/04 (2006.01) (US); Dirk Trauner, San Francisco, CA CI2P 2/06 (2006.01) (US); Matthew R. Banghart, Oakland, CI2N 15/74 (2006.01) CA (US); Matthew Volgraf, Oakland, CI2N I/2 (2006.01) CA (US); Pablo Ignacio Gorostiza A6II 38/16 (2006.01) Langa, Barcelona (ES) (52) U.S. Cl. ...................... 435/7.1; 435/69.1; 435/252.3: 435/471; 530/350, 536/23.5; Correspondence Address: 514f12 BOZICEVIC, FIELD & FRANCIS LLP 1900 UNIVERSITY AVENUE SUTE 200 (57) ABSTRACT EAST PALO ALTO, CA 94.303 (US) The present invention provides a synthetic regulator of Appl. No.: 11/601,591 protein function, which regulator is a light-sensitive regu (21) lator. The present invention further provides a light-regu (22) Filed: Nov. 17, 2006 lated polypeptide that includes a subject synthetic regulator. Also provided are cells and membranes comprising a subject Related U.S. Application Data light-regulated polypeptide. The present invention further provides methods of modulating protein function, involving (60) Provisional application No. 60/737,935, filed on Nov. use of light. The present invention further provides methods 18, 2005. of identifying agents that modulate protein function. Patent Application Publication Jun. 7, 2007 Sheet 1 of 34 US 2007/O128662 A1 F.G. 1 a MAL-AZO-GRA Patent Application Publication Jun. 7, 2007 Sheet 2 of 34 US 2007/0128662 A1 FIG 2 3. b 350 30 Ontrol Control Control 2 O Block UV Vis. eO 250 C S. g 200 C O 150 100 O 2 4 8 6 10 Time (min) C d 72 ZDZZZZZTAZZZZZ M 1000 200 ZZ Wis. Dark 800 OUV 150 ZVis. 2 2 OUV 9- 600 Soo E wa 95 400 50 O ( ) 200 O O O 2 4 6 8 10 2 14 16 O 50 100 150 200 250 300 Time (min) Time (s) Patent Application Publication Jun. 7, 2007 Sheet 3 of 34 US 2007/0128662 A1 3. b 500 360 340 380 400 420 500 0.25 100 0.20 tranS 3 a. 80 is 0.15 CC -S 9 60 3 0.10 40 -O s a 0.05 cis O 20 0.00 O 250 300 350 400 450 500 550 O 5 10 15 20 Wavelength (nm) Time (min) C d 1.0 1.O 2 30.85 0.85-Y s O O D S 0.6 06 P s W. Y cus E.N 0.4 0.4.S25 s O 5 E 5 s Z 0.0-0 0.0 O.O 0.2 0.4 0.6 0.8 10 320 360 400 440 480 520 560 600 Time (min) Wavelength (nm) FIG. 3 Patent Application Publication Jun. 7, 2007 Sheet 4 of 34 US 2007/0128662 A1 3. I S&T DXX X& mV 500 390 nt nm. 10 S b mV 50 mS C 7 6 500 nm 9 5 O 390 nm s on 4 5 is 3 2S 2 Z MAL-AZO-QA MAL-AZO-QA Shaker + Shaker FIG. 4 Patent Application Publication Jun. 7, 2007 Sheet 5 of 34 US 2007/O128662 A1 FIG. 5A Patent Application Publication Jun. 7, 2007 Sheet 6 of 34 US 2007/O128662 A1 -OOC1)-1 COO 2: (2S,4R)-4-allylglutamate H O 6 H NH -OOc1N1 coo 3: Tether model F.G. 6B AZObenzene Maleimide N O TranS y - C's,N Ki C 1N1as '''3 O H 4: MAG OOC COO 380m 500 nm Agonist O N // O O N O H on Cis OOC HN *-n-so -OOc'NH; Patent Application Publication Jun. 7, 2007 Sheet 7 of 34 US 2007/O128662 A1 FIG. 6C -OOc1N1 coo Patent Application Publication Jun. 7, 2007 Sheet 8 of 34 US 2007/O128662 A1 O.J.'SDI uluu9 Patent Application Publication Jun. 7, 2007 Sheet 9 of 34 US 2007/O128662 A1 H NH 1NH ''O Hera,b NSNs O 2 HN HN 5: Azodianiline 6 O l Ho' C de f-h o-cooh s o-cooE Hair o?-cooE -- H Boc BOC 7: L-Pyroglutamic acid 8 9 H N-N NC 5 H i-k H.N- N C 10 H o-cooE BOC H (ii, C NC5N ge O N HOOC1N1COOH 4: MAGHC Patent Application Publication Jun. 7, 2007 Sheet 10 of 34 US 2007/O128662 A1 FIG 9A glu 300 M 6OO 500 s 400 3OO FIG. 9B tether model (nM) glu 300 um 3 1 O.3 0.10.01 Patent Application Publication Jun. 7, 2007 Sheet 11 of 34 US 2007/O128662 A1 FIG 10 O gyu. NH ooc1\1COO nic Q H O 3: Tether model '''d) H NH 3 Patent Application Publication Jun. 7, 2007 Sheet 12 of 34 US 2007/O128662 A1 A 51.00 al 0.75 w UDs 0,50 2 0.25 600 E500 Sooo 400 300 400 SOO 600 3OO excitation wavelength (nm) D 3S 1.00 s 0.75 E to so ge s N se gas 9Sis via 2000 3oo Too r so" so excitation wavelength (nm) 05 - excitation wavelength (nm) Patent Application Publication Jun. 7, 2007 Sheet 13 of 34 US 2007/O128662 A1 FIG. 12 A 2ootooooooo time (min) B 200 pA 2 min Patent Application Publication Jun. 7, 2007 Sheet 14 of 34 US 2007/0128662 A1 FIG. 13 A B 500 nm. 380 nm O O. /1BDy O Glu O)."A G e C gluReimsoniii. D glu glu 300M glu MAG 100nM glu 300uM + MAG 100nM 300uM R" 36M A \A".is 380/500nm - 380/500mm 10 min Patent Application Publication Jun. 7, 2007 Sheet 15 of 34 US 2007/O128662 A1 FIG. 14 300 uM glu 1 nA 1 OS 600 Patent Application Publication Jun. 7, 2007 Sheet 16 of 34 US 2007/0128662 A1 miOOZmioOLQmioO£ W uopenueouoso emoee | XONG] esuodsel empeau Patent Application Publication Jun. 7, 2007 Sheet 17 of 34 US 2007/0128662 A1 FIG. 16 &83§8. NZ MAG-1 MAG-2 photoswitch length D NYNY MAG-1 MAG-2 MAG-1 MAG-2 photoswitch length photoswitch length Patent Application Publication Jun. 7, 2007 Sheet 18 of 34 US 2007/0128662 A1 H N1 -- N(4. -/ O H Z cºmºaegae, Z k O o? Cy <!--N C Patent Application Publication Jun. 7, 2007 Sheet 19 of 34 US 2007/O128662 A1 s 3 S. s SuluoMSoloud 9, 3 e US Ozzy S e or a v ( e. vo so O O. O. O. fuuoAASOoud 9. (vod) ueluno (9 Patent Application Publication Jun. 7, 2007 Sheet 20 of 34 US 2007/O128662 A1 8 s C 0 to r (N. c. vie C C C C C. f5uguo MSoloud 9, () Patent Application Publication Jun. 7, 2007 Sheet 21 of 34 US 2007/O128662 A1 FG. 20 b O DDO O". OO ... OOO OO |- S Patent Application Publication Jun. 7, 2007 Sheet 22 of 34 US 2007/0128662 A1 FIG 21 15 min 80 60 min Patent Application Publication Jun. 7, 2007 Sheet 25 of 34 US 2007/0128662 A1 (ZH) / e3e LoMS 3 C O v ve - ve s 88 9. s epndue pezieuou Patent Application Publication Jun. 7, 2007 Sheet 26 of 34 US 2007/O128662 A1 mm,.~~~~); E. C) Patent Application Publication Jun. 7, 2007 Sheet 27 of 34 US 2007/O128662 A1 FIG. 26 21 Hz. 4oo . 400 is t 5 SH somy E 400 is logou Isusual so SOO be as a D SSHz 4 O - also III Bl E. OO . Patent Application Publication Jun. 7, 2007 Sheet 28 of 34 US 2007/0128662 A1 FIG. 27 2 - -20 D E-40 > -60 -80 to500 E b 20 mV 10 sec < 500 Patent Application Publication Jun. 7, 2007 Sheet 29 of 34 US 2007/O128662 A1 TipTTT 5 (uu). Patent Application Publication Jun. 7, 2007 Sheet 30 of 34 US 2007/0128662 A1 Patent Application Publication Jun. 7, 2007 Sheet 31 of 34 US 2007/0128662 A1 FIG. 30 Patent Application Publication Jun. 7, 2007 Sheet 32 of 34 US 2007/0128662 A1 FIG 31 Patent Application Publication Jun. 7, 2007 Sheet 33 of 34 US 2007/O128662 A1 FIG. 32 500 nm 380 nm 10 sec 500 m 380 nm 2 mSec Patent Application Publication Jun. 7, 2007 Sheet 34 of 34 US 2007/0128662 A1 US 2007/0128662 A1 Jun. 7, 2007 PHOTOREACTIVE REGULATOR OF PROTEIN 0010 FIGS. 3A-D depict absorbance and action spectra FUNCTION AND METHODS OF USE THEREOF of MAL-AZO-QA. 0011 FIGS. 4A-C depict expression of light-activated CROSS-REFERENCE channels confers light-sensitivity on hippocampal pyramidal 0001) This application claims the benefit of U.S. Provi UOS. sional Patent Application No. 60/737,935, filed Nov. 18, 0012 FIGS. 5A-C schematically depict a design of an 2005, which application is incorporated herein by reference allosteric photoswitch. in its entirety. 0013 FIGS. 6A-D depict structures and fit of photo switched agonist and iGluR6 LBD. (a) Chemical structure of STATEMENT REGARDING FEDERALLY the iGluR6 agonists (2S,4R)-4-methylglutamate 1, (2S,4R)- SPONSORED RESEARCH 4-allyl glutamate 2 and tether model 3. 0002 The U.S. government may have certain rights in 0014 FIGS. 7A-E depict calcium imaging of iGluR6 this invention, pursuant to grant no.
Load more

Recommended publications
  • CILICIA: the FIRST CHRISTIAN CHURCHES in ANATOLIA1 Mark Wilson
    CILICIA: THE FIRST CHRISTIAN CHURCHES IN ANATOLIA1 Mark Wilson Summary This article explores the origin of the Christian church in Anatolia. While individual believers undoubtedly entered Anatolia during the 30s after the day of Pentecost (Acts 2:9–10), the book of Acts suggests that it was not until the following decade that the first church was organized. For it was at Antioch, the capital of the Roman province of Syria, that the first Christians appeared (Acts 11:20–26). Yet two obscure references in Acts point to the organization of churches in Cilicia at an earlier date. Among the addressees of the letter drafted by the Jerusalem council were the churches in Cilicia (Acts 15:23). Later Paul visited these same churches at the beginning of his second ministry journey (Acts 15:41). Paul’s relationship to these churches points to this apostle as their founder. Since his home was the Cilician city of Tarsus, to which he returned after his conversion (Gal. 1:21; Acts 9:30), Paul was apparently active in church planting during his so-called ‘silent years’. The core of these churches undoubtedly consisted of Diaspora Jews who, like Paul’s family, lived in the region. Jews from Cilicia were members of a Synagogue of the Freedmen in Jerusalem, to which Paul was associated during his time in Jerusalem (Acts 6:9). Antiochus IV (175–164 BC) hellenized and urbanized Cilicia during his reign; the Romans around 39 BC added Cilicia Pedias to the province of Syria. Four cities along with Tarsus, located along or near the Pilgrim Road that transects Anatolia, constitute the most likely sites for the Cilician churches.
    [Show full text]
  • Chronic Social Isolation Reduces 5-HT Neuronal Activity Via Upregulated SK3 Calcium-Activated Potassium Channels Derya Sargin1, David K Oliver1, Evelyn K Lambe1,2,3*
    SHORT REPORT Chronic social isolation reduces 5-HT neuronal activity via upregulated SK3 calcium-activated potassium channels Derya Sargin1, David K Oliver1, Evelyn K Lambe1,2,3* 1Department of Physiology, University of Toronto, Toronto, Canada; 2Department of Obstetrics and Gynaecology, University of Toronto, Toronto, Canada; 3Department of Psychiatry, University of Toronto, Toronto, Canada Abstract The activity of serotonin (5-HT) neurons is critical for mood regulation. In a mouse model of chronic social isolation, a known risk factor for depressive illness, we show that 5-HT neurons in the dorsal raphe nucleus are less responsive to stimulation. Probing the responsible cellular mechanisms pinpoints a disturbance in the expression and function of small-conductance Ca2+-activated K+ (SK) channels and reveals an important role for both SK2 and SK3 channels in normal regulation of 5-HT neuronal excitability. Chronic social isolation renders 5-HT neurons insensitive to SK2 blockade, however inhibition of the upregulated SK3 channels restores normal excitability. In vivo, we demonstrate that inhibiting SK channels normalizes chronic social isolation- induced anxiety/depressive-like behaviors. Our experiments reveal a causal link for the first time between SK channel dysregulation and 5-HT neuron activity in a lifelong stress paradigm, suggesting these channels as targets for the development of novel therapies for mood disorders. DOI: 10.7554/eLife.21416.001 Introduction *For correspondence: evelyn. Major depression is a prevalent and debilitating disease for which standard treatments remain inef- [email protected] fective. Social isolation has long been implicated as a risk factor for depression in humans Competing interests: The (Cacioppo et al., 2002,2006; Holt-Lunstad et al., 2010) and induces anxiety- and depressive-like authors declare that no behaviors in rodents (Koike et al., 2009; Wallace et al., 2009; Dang et al., 2015; Shimizu et al., competing interests exist.
    [Show full text]
  • Apamin As a Selective Blocker of the Calcium-Dependent Potassium
    Proc. NatL Acad. Sci. USA Vol. 79, pp. 1308-1312, February 1982 Neurobiology Apamin as a selective blocker of the calcium-dependent potassium channel in neuroblastoma cells: Voltage-clamp and biochemical characterization of the toxin receptor (receptor binding/neuroblastoma cell differentiation) M. HUGUES, G. ROMEY, D. DUVAL, J. P. VINCENT, AND M. LAZDUNSKI Centre de Biochimie du Centre National de la Recherche Scientifique, Facult, des Sciences, Parc Valrose, 06034 Nice Cedex, France Communicated by Jean-Marie P. Lehn, October 13, 1981 ABSTRACT This paper describes the interaction of apamin, MATERIALS AND METHODS a bee venom neurotoxin, with the mouse neuroblastoma cell mem- brane. Voltage-clamp analyses have shown thatapamin atlowcon- Cultures of Neuroblastoma Cells. Neuroblastoma cells centrations specifically blocks the Ca2"-dependent K+ channel in (clone N1E 115) were grown as described (12); they were in- differentiated neuroblastoma cells. Binding experiments with duced to differentiate in the presence of1% fetal calfserum and highly radiolabeled toxin indicate that the dissociation constant of 1.5% dimethyl sulfoxide. the apamin-receptor complex in differentiated neuroblastoma lodination ofApamin. Apamin was purified as described (13). cells is 15-22 pM and the maximal binding capacity is 12 fmol/ There is no tyrosine residue in the sequence, but there is his- mg ofprotein. The receptor is destroyed by proteases, suggesting tidine residue that is not essential for activity (4) and that can that it is a protein.The binding capacity ofneuroblastoma cells for be iodinated. It has been found that the previously radiolabeled apamin dramatically increases during the transition described to prepare "2I-labeled apamin ('p9rocedureI-apamin) (14) could from the nondifferentiated to the differentiated state.
    [Show full text]
  • Greece • Crete • Turkey May 28 - June 22, 2021
    GREECE • CRETE • TURKEY MAY 28 - JUNE 22, 2021 Tour Hosts: Dr. Scott Moore Dr. Jason Whitlark organized by GREECE - CRETE - TURKEY / May 28 - June 22, 2021 May 31 Mon ATHENS - CORINTH CANAL - CORINTH – ACROCORINTH - NAFPLION At 8:30a.m. depart from Athens and drive along the coastal highway of Saronic Gulf. Arrive at the Corinth Canal for a brief stop and then continue on to the Acropolis of Corinth. Acro-corinth is the citadel of Corinth. It is situated to the southwest of the ancient city and rises to an elevation of 1883 ft. [574 m.]. Today it is surrounded by walls that are about 1.85 mi. [3 km.] long. The foundations of the fortifications are ancient—going back to the Hellenistic Period. The current walls were built and rebuilt by the Byzantines, Franks, Venetians, and Ottoman Turks. Climb up and visit the fortress. Then proceed to the Ancient city of Corinth. It was to this megalopolis where the apostle Paul came and worked, established a thriving church, subsequently sending two of his epistles now part of the New Testament. Here, we see all of the sites associated with his ministry: the Agora, the Temple of Apollo, the Roman Odeon, the Bema and Gallio’s Seat. The small local archaeological museum here is an absolute must! In Romans 16:23 Paul mentions his friend Erastus and • • we will see an inscription to him at the site. In the afternoon we will drive to GREECE CRETE TURKEY Nafplion for check-in at hotel followed by dinner and overnight. (B,D) MAY 28 - JUNE 22, 2021 June 1 Tue EPIDAURAUS - MYCENAE - NAFPLION Morning visit to Mycenae where we see the remains of the prehistoric citadel Parthenon, fortified with the Cyclopean Walls, the Lionesses’ Gate, the remains of the Athens Mycenaean Palace and the Tomb of King Agamemnon in which we will actually enter.
    [Show full text]
  • Antimicrobial Activity of Apitoxin, Melittin and Phospholipase A2 of Honey Bee (Apis Mellifera) Venom Against Oral Pathogens
    Anais da Academia Brasileira de Ciências (2015) 87(1): 147-155 (Annals of the Brazilian Academy of Sciences) Printed version ISSN 0001-3765 / Online version ISSN 1678-2690 http://dx.doi.org/10.1590/0001-3765201520130511 www.scielo.br/aabc Antimicrobial activity of apitoxin, melittin and phospholipase A2 of honey bee (Apis mellifera) venom against oral pathogens LUÍS F. LEANDRO, CARLOS A. MENDES, LUCIANA A. CASEMIRO, ADRIANA H.C. VINHOLIS, WILSON R. CUNHA, ROSANA DE ALMEIDA and CARLOS H.G. MARTINS Laboratório de Pesquisas em Microbiologia Aplicada (LaPeMA), Universidade de Franca, Av. Dr. Armando Salles Oliveira, 201, Bairro Parque Universitário, 14404-600 Franca, SP, Brasil Manuscript received on November 19, 2013; accepted for publication on June 30, 2014 ABSTRACT In this work, we used the Minimum Inhibitory Concentration (MIC) technique to evaluate the antibacterial potential of the apitoxin produced by Apis mellifera bees against the causative agents of tooth decay. Apitoxin was assayed in natura and in the commercially available form. The antibacterial actions of the main components of this apitoxin, phospholipase A2, and melittin were also assessed, alone and in combination. The following bacteria were tested: Streptococcus salivarius, S. sobrinus, S. mutans, S. mitis, S. sanguinis, Lactobacillus casei, and Enterococcus faecalis. The MIC results obtained for the commercially available apitoxin and for the apitoxin in natura were close and lay between 20 and 40µg / mL, which indicated good antibacterial activity. Melittin was the most active component in apitoxin; it displayed very promising MIC values, from 4 to 40µg / mL. Phospholipase A2 presented MIC values higher than 400µg / mL. Association of mellitin with phospholipase A2 yielded MIC values ranging between 6 and 80µg / mL.
    [Show full text]
  • Mediterranean Divine Vintage Turkey & Greece
    BULGARIA Sinanköy Manya Mt. NORTH EDİRNE KIRKLARELİ Selimiye Fatih Iron Foundry Mosque UNESCO B L A C K S E A MACEDONIA Yeni Saray Kırklareli Höyük İSTANBUL Herakleia Skotoussa (Byzantium) Krenides Linos (Constantinople) Sirra Philippi Beikos Palatianon Berge Karaevlialtı Menekşe Çatağı Prusias Tauriana Filippoi THRACE Bathonea Küçükyalı Ad hypium Morylos Neapolis Dikaia Heraion teikhos Achaeology Edessa park KOCAELİ Tragilos Antisara Perinthos Basilica UNESCO Abdera Maroneia TEKİRDAĞ (İZMİT) DÜZCE Europos Kavala Doriskos Nicomedia Pella Amphipolis Stryme Işıklar Mt. ALBANIA JOINAllante Lete Bormiskos Thessalonica Argilos THE SEA OF MARMARA SAKARYA MACEDONIANaoussa Apollonia Thassos Ainos (ADAPAZARI) UNESCO Thermes Aegae YALOVA Ceramic Furnaces Selectum Chalastra Strepsa Berea Iznik Lake Nicea Methone Cyzicus Vergina Petralona Samothrace Parion Roman theater Acanthos Zeytinli Ada Apamela Aisa Ouranopolis Hisardere Elimia PydnaMEDITERRANEAN Barçın Höyük BTHYNIA Dasaki Galepsos Yenibademli Höyük BURSA UNESCO Antigonia Thyssus Apollonia (Prusa) ÇANAKKALE Manyas Zeytinlik Höyük Arisbe Lake Ulubat Phylace Dion Akrothooi Lake Sane Parthenopolis GÖKCEADA Aktopraklık O.Gazi Külliyesi BİLECİK Asprokampos Kremaste Daskyleion UNESCO Höyük Pythion Neopolis Astyra Sundiken Mts. Herakleum Paşalar Sarhöyük Mount Athos Achmilleion Troy Pessinus Potamia Mt.Olympos Torone Hephaistia Dorylaeum BOZCAADA Sigeion Kenchreai Omphatium Gonnus Skione Limnos MYSIA Uludag ESKİŞEHİR Eritium DIVINE VINTAGE Derecik Basilica Sidari Oxynia Myrina Kaz Mt. Passaron Soufli Troas Kebrene Skepsis UNESCO Meliboea Cassiope Gure bath BALIKESİR Dikilitaş Kanlıtaş Höyük Aiginion Neandra Karacahisar Castle Meteora Antandros Adramyttium Corfu UNESCO Larissa Lamponeia Dodoni Theopetra Gülpinar Pioniai Kulluoba Hamaxitos Seyitömer Höyük Keçi çayırı Syvota KÜTAHYA Grava Polimedion Assos Gerdekkaya Assos Mt.Pelion A E GTURKEY E A N S E A &Pyrrha GREECEMadra Mt. (Cotiaeum) Kumbet Lefkimi Theudoria Pherae Mithymna Midas City Ellina EPIRUS Passandra Perperene Lolkos/Gorytsa Antissa Bahses Mt.
    [Show full text]
  • Top-Down Sequencing of Apis Dorsata Apamin by MALDI-TOF MS and Evidence of Its Inactivity Against Microorganisms
    Toxicon 71 (2013) 105–112 Contents lists available at SciVerse ScienceDirect Toxicon journal homepage: www.elsevier.com/locate/toxicon Top-down sequencing of Apis dorsata apamin by MALDI-TOF MS and evidence of its inactivity against microorganisms D. Baracchi a,*, G. Mazza a, E. Michelucci b, G. Pieraccini b, S. Turillazzi a,b, G. Moneti b a Department of Biologia Evoluzionistica “Leo Pardi”, University of Firenze, Via Romana 17, 50125 Firenze, Italy b Mass Spectrometry Centre, University of Firenze, Viale G. Pieraccini 6, 50139 Firenze, Italy article info abstract Article history: Apis mellifera venom is one of the best characterized venoms among Hymenoptera, yet Received 13 March 2013 relatively little is known about venom belonging to other species in the genus Apis. Received in revised form 18 May 2013 Melittin, one of the most important bioactive peptides, has been isolated and characterized Accepted 22 May 2013 in A. mellifera, Apis cerana, Apis dorsata and Apis florea, while apamin has been only Available online 7 June 2013 characterized in A. mellifera and A. cerana. At present, no information is available about the sequence of A. dorsata apamin. Moreover, while the antiseptic properties of melittin and Keywords: MCD peptides are well documented, the antimicrobial activity of apamin has never been MALDI-TOF Venom tested. In the present study, we isolated and characterized apamin from the venom of the Honeybee giant honeybee A. dorsata. We tested the activity of apamin against bacteria and yeasts in a Antimicrobial peptides microbiological assay to gain a more complete understanding of the antimicrobial Peptide sequencing competence of the medium molecular weight venom fraction.
    [Show full text]
  • Synthesis and Structure-Activity Studies of Novel Potassium K+ Ion
    P^ge Urn Replace with 30 8 ...its responce being... ...and its response is... 31 1 Dispite... Despite... 32 10 These channels were... This channel was... 33 5 ...and can be envisaged... ...and it can be envisaged... 38 13 ...with rise... ...with a rise... 42 11 etal etal. 42 13 ...of Lys^... ...or Lys^... 43 15 etal etal. 44 16 etal etal. 45 7 etal etal. 48 13 Concequently... Consequently... 49 1 etal etal. 52 14 etal etal. 52 25 ...suggeted... ...suggested... 60 2 etal etal. 77 14 ...quatermaiy... ...quaternary... 79 3 ...whch... ...which... 82 9 ...appart... ...apart... 99 6 ...excert... ...exert... 104 entry 14 26.0 + 14 26 ±14 109 9 ...propeiies... ...properties... 122 7 ...accosiated... ...associated... 123 4 —Elumo consists... -E lumo provides... 123 5 ...ralationships... ...relationships... 124 12 etal etal. 131 4 ...section 2.3... ...section 2.4... 133 12 ...IC-jS... ...Ki values... 133 13 ...500 times... ...50 times... 135 Table Kcal/raol kcal/mol 135 11 Kcal/mol kcal/mol 136 6 Kcal/mol kcal/mol 136 23 Kcal/mol kcal/mol 136 26 Kcal/mol kcal/mol 136 27 Kcal/mol kcal/mol 137 13 Kcal/mol kcal/mol 137 14 Kcal/mol kcal/mol 137 15 Kcal/mol kcal/mol 137 16 Kcal/mol kcal/mol 138 6 Kcal/mol kcal/mol 138 Table KcalAnol kcal/mol 139 9 Kcal/mol kcal/mol 139 Table Kcal/mol kcal/mol 140 Table Kcal/mol kcal/mol 141 10 Kcal/mol kcal/mol 141 12 Kcal/mol kcal/mol 143 6 ...space i.e.... ...space, i.e...
    [Show full text]
  • Kuzey Lydia'da Lykos Vadisi'nin Tarihsel Coğrafyası Historical Geography of the Lycus Valley in Northern Lydia
    e-ISSN: 2149-7826 Disiplinlerarası Akdeniz Araştırmaları Dergisi Journal of Interdisciplinary Mediterranean Studies journal.phaselis.org Issue IV (2018) Kuzey Lydia'da Lykos Vadisi'nin Tarihsel Coğrafyası Historical Geography of the Lycus Valley in Northern Lydia Esen ÖĞÜŞ The entire contents of this journal, Phaselis: Journal of Interdisciplinary Mediterranean Studies, is open to users and it is an ‘open access’ journal. Users are able to read the full texts, to download, to copy, print and distribute without obtaining the permission of the editor and author(s). However, all references to the articles published in the e-journal Phaselis are to indicate through reference the source of the citation from this journal. Phaselis: Journal of Interdisciplinary Mediterranean Studies is a peer-reviewed journal and the articles which have had their peer reviewing process completed will be published on the web-site (journal.phaselis.org) in the year of the journal’s issue (e.g. Issue III: January- December 2017). At the end of December 2017 the year’s issue is completed and Issue IV: January-December 2018 will begin. Responsibility for the articles published in this journal remains with the authors. Citation E. Öğüş, “Kuzey Lydia'da Lykos Vadisi'nin Tarihsel Coğrafyası”. Phaselis IV (2018) 325-342. http://dx.doi.org/10.18367/Pha.18019 Received Date: 15.10.2018 | Acceptance Date: 29.10.2018 Online Publication Date: 12.11.2018 Editing Phaselis Research Project www.phaselis.org journal.phaselis.org IV (2018) 325-342 DOI: 10.18367/Pha.18019 Kuzey Lydia'da Lykos Vadisi'nin Tarihsel Coğrafyası Historical Geography of the Lycus Valley in Northern Lydia Esen ÖĞÜŞ Öz: Kuzey Lydia'daki, güneydoğusunda Sardeis, kuzeybatısında ise Pergamon kentleri arasında bulunan Lykos (Gördük Çayı) Vadisi'nin kentleşme tarihi cevaplanmamış birçok soruyu beraberinde getirir.
    [Show full text]
  • Philip II of Macedon: a Consideration of Books VII IX of Justin's Epitome of Pompeius Trogus
    Durham E-Theses Philip II of Macedon: a consideration of books VII IX of Justin's epitome of Pompeius Trogus Wade, J. S. How to cite: Wade, J. S. (1977) Philip II of Macedon: a consideration of books VII IX of Justin's epitome of Pompeius Trogus, Durham theses, Durham University. Available at Durham E-Theses Online: http://etheses.dur.ac.uk/10215/ Use policy The full-text may be used and/or reproduced, and given to third parties in any format or medium, without prior permission or charge, for personal research or study, educational, or not-for-prot purposes provided that: • a full bibliographic reference is made to the original source • a link is made to the metadata record in Durham E-Theses • the full-text is not changed in any way The full-text must not be sold in any format or medium without the formal permission of the copyright holders. Please consult the full Durham E-Theses policy for further details. Academic Support Oce, Durham University, University Oce, Old Elvet, Durham DH1 3HP e-mail: [email protected] Tel: +44 0191 334 6107 http://etheses.dur.ac.uk 2 The copyright of this thesis rests with the author. No quotation from it should be published without his prior written consent and information derived from it should be acknowledged. PHILIP II OF MACEDON: A CONSIDERATION OF BOOKS VII - IX OF JUSTIN* S EPITOME OF POMPEIUS TROGUS THESIS SUBMITTED IN APPLICATION FOR THE DEGREE OF MASTER OF ARTS - by - J. S. WADE, B. A. DEPARTMENT OF CLASSICS UNIVERSITY OF DURHAM OCTOBER 1977 ABSTRACT The aim of this dissertation is two-fold: firstly to examine the career and character of Philip II of Macedon as portrayed in Books VII - IX of Justin's epitome of the Historiae Phillppicae .of Pompeius Trqgus, and to consider to what extent Justin-Trogus (a composite name for the author of the views in the text of Justin) furnishes accurate historical fact, and to what extent he paints a one-sided interpretation of the events, and secondly to identify as far as possible Justin's principles of selection and compression as evidenced in Books VII - IX.
    [Show full text]
  • Coverpage Final
    Symbols and Objects on the Sealings from Kedesh A DISSERTATION SUBMITTED TO THE FACULTY OF THE GRADUATE SCHOOL OF THE UNIVERSITY OF MINNESOTA BY Paul Lesperance IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY Professor Andrea Berlin August 2010 © Paul Lesperance, 2010 Acknowledgements I have benefitted greatly from the aid and support of many people and organizations during the writing of this dissertation. I would especially like to thank my advisor, Professor Andrea Berlin, for all her help and advice at all stages of the production process as well as for suggesting the topic to me in the first place. I would also like to thank all the members of my dissertation committee (Professor Susan Herbert of the University of Michigan, as well as Professors Philip Sellew and Nita Krevans of the University of Minnesota) for all their help and support. During the writing process, I benefitted greatly from a George A. Barton fellowship to the W. F. Albright Institute of Archaeological Research in Jerusalem in the fall of 2009. I would like to thank the fellowship committee for giving me such a wonderful and productive opportunity that helped me greatly in this endeavour as well as the staff of the Albright for their aid and support. I would also like to thank both Dr. Donald Ariel of the Israel Antiquities Authority for his aid in getting access to the material and his valuable advice in ways of looking at it and Peter Stone of the University of Cincinnati whose discussions on his work on the pottery from Kedesh helped to illuminate various curious aspects of my own.
    [Show full text]
  • Crucial Role of a Shared Extracellular Loop in Apamin Sensitivity and Maintenance of Pore Shape of Small- Conductance Calcium-Activated Potassium (SK) Channels
    Crucial role of a shared extracellular loop in apamin sensitivity and maintenance of pore shape of small- conductance calcium-activated potassium (SK) channels Kate L. Weatheralla, Vincent Seutinb, Jean-François Liégeoisc, and Neil V. Marriona,1 aSchool of Physiology and Pharmacology, University of Bristol, Bristol BS8 1TD, United Kingdom; and Laboratories of bPharmacology and Groupe Interdisciplinaire de Génoprotéomique Appliquée-Neuroscience and cCentre Interfacultaire de Recherche du Médicament, University of Liège, B-4000 Liège, Belgium Edited by Michael D. Cahalan, University of California, Irvine, CA, and approved September 29, 2011 (received for review July 3, 2011) Activation of small-conductance calcium (Ca2+)-dependent potas- apamin does not behave as a classical pore blocker, but blocks sium (KCa2) channels (herein called “SK”) produces membrane hy- using an allosteric mechanism (7). Apamin also interacts with perpolarization to regulate membrane excitability. Three subtypes a serine residue in the S3–S4 extracellular loop to impart a high- (SK1–3) have been cloned and are distributed throughout the ner- sensitivity block of SK2, with mutation of the corresponding vous system, smooth muscle, and heart. It is difficult to discern the threonine in hSK1 to a serine increasing sensitivity of block of physiological role of individual channel subtypes as most blockers hSK1 by the toxin (8). Block of SK channel current by apamin is or enhancers do not discriminate between subtypes. The archetyp- clearly more complicated than these data suggest, as despite ical blocker apamin displays some selectivity between SK channel containing an identical outer pore sequence to the apamin-sen- – subtypes, with SK2 being the most sensitive, followed by SK3 and sitive hSK1 and a serine in this position in the S3 S4 loop, rSK1 – then SK1.
    [Show full text]